http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/Article/list/48329 The publisher of Pharmaceutical Executive brings visitors PharmExec.com, which serves up a daily dose of news and features from the world of pharma business and marketing. 2013-05-24T17:52:53Z http://www.pharmexec.com/pharmexec/Europe/Sweden-takes-the-reins/ArticleStandard/Article/detail/619739?contextCategoryId=48329&ref=25 The presence of a high-flying Obama administration insider at the upcoming Swedish life sciences summit is just one indication of the seriousness with which the country taking its EU presidency. 2009-08-25T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/342009/619739null HTML http://www.pharmexec.com/pharmexec/Europe+Features/Belgiums-statin-stalemate/ArticleStandard/Article/detail/616342?contextCategoryId=48329&ref=25 Reflector reports on how Belgium's best intentions have backfired on its generics manufacturers. 2009-08-11T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/322009/616342null HTML http://www.pharmexec.com/pharmexec/Europe/The-EC-antitrust-report-results-are-in-Time-to-pop/ArticleStandard/Article/detail/612916?contextCategoryId=48329&ref=25 The climax of the antitrust investigation instigated with all guns blazing by EC commissioner Neelie Kroes last year has been a whimper, not a bang. Reflector reports. 2009-07-28T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/302009/612916null HTML http://www.pharmexec.com/pharmexec/Europe+Features/Big-Pharma-isnt-dead-but-long-live-small-pharma/ArticleStandard/Article/detail/610857?contextCategoryId=48329&ref=25 As the major companies grapple with various crises from patent expirations to regulatory clampdowns, Reflector looks at how small pharma is coming into its own. 2009-07-14T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/292009/610857null HTML http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/Big-Pharma-muscling-further-into-Brussels/ArticleStandard/Article/detail/603136?contextCategoryId=48329&ref=25 News of the potential Solvay sale has sent the company's stock soaring, but is it good news for Belgium? Reflector reports. 2009-04-28T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603136null HTML http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/Pharma-on-thin-ice/ArticleStandard/Article/detail/603137?contextCategoryId=48329&ref=25 Reflector points to a number of recent alarm signals that have seen European pharma move further towards dangerous territory. 2009-04-14T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603137null HTML http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/An-uphill-struggle-for-European-Pharma/ArticleStandard/Article/detail/603138?contextCategoryId=48329&ref=25 Reflector ponders recent events in the battle against counterfeit drugs. 2009-03-31T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603138null HTML http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/Does-Brussels-need-a-wake-up-call-on-medicines/ArticleStandard/Article/detail/603139?contextCategoryId=48329&ref=25 Reflector ponders the growing gap between the US and Europe's vision for the future of drug marketing. 2009-03-17T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603139null HTML http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/EU-and-industry-in-shock-agreement/ArticleStandard/Article/detail/603140?contextCategoryId=48329&ref=25 Reflector welcomes the signs of EU agreement on encouraging the development of rare disease treatments. 2009-02-24T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603140null HTML http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/Can-Mandy-save-the-life-sciences-industry/ArticleStandard/Article/detail/603141?contextCategoryId=48329&ref=25 Reflector wonders whether the UK government's business supremo can work his magic on European pharma and biotech. 2009-02-10T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603141null HTML http://www.pharmexec.com/pharmexec/Europe%3A+Reflector/Prescription-Drug-Advertising-Same-Debate-Differen/ArticleStandard/Article/detail/603142?contextCategoryId=48329&ref=25 Reflector casts doubt on European pharma's vision for further communication between the industry and its patients. 2009-01-20T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242009/603142null HTML